129 related articles for article (PubMed ID: 7200773)
1. Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.
Hornby EJ; Skidmore IF
Biochem Pharmacol; 1982 Mar; 31(6):1158-60. PubMed ID: 7200773
[No Abstract] [Full Text] [Related]
2. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
[No Abstract] [Full Text] [Related]
3. Nicotinic acid inhibits thromboxane synthesis in platelets.
Vincent JE; Zijlstra FJ
Prostaglandins; 1978 Apr; 15(4):629-36. PubMed ID: 674694
[No Abstract] [Full Text] [Related]
4. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
Fitzpatrick FA; Gorman RR
Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
6. The biochemical pharmacology of thromboxane synthase inhibition in man.
FitzGerald GA; Reilly IA; Pedersen AK
Circulation; 1985 Dec; 72(6):1194-201. PubMed ID: 3905048
[TBL] [Abstract][Full Text] [Related]
7. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
8. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
Mallarkey G; Smith GM
Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
[TBL] [Abstract][Full Text] [Related]
10. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
Nishizawa EE; Williams DJ; Connell CL
Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological action on the thromboxane and prostacyclin balance in the body].
Lakin KM; Makarov VA; Novikova NV; Tret'iak VM; Rukazenkov IuE
Farmakol Toksikol; 1984; 47(2):67-79. PubMed ID: 6425078
[No Abstract] [Full Text] [Related]
12. [Role of prostacyclin and thromboxane A2 in the cardiovascular system].
Ismailov ShI; Val'dman AV
Kardiologiia; 1981 Mar; 21(3):111-6. PubMed ID: 7014974
[No Abstract] [Full Text] [Related]
13. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Moncada S; Vane JR
Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
[No Abstract] [Full Text] [Related]
14. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
Allan G; Eakins KE; Kulkarni PS; Levi R
Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
Svensson J
Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
19. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Miller OV; Ayer DE; Gorman RR
Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
[TBL] [Abstract][Full Text] [Related]
20. The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
Bunting S; Moncada S; Vane JR
Br Med Bull; 1983 Jul; 39(3):271-6. PubMed ID: 6354352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
